Schcolnik-Cabrera Alejandro, Vega-Memije Elisa, Hernández-Castro Rigoberto, Arenas Roberto, Fernández-Martínez Ramón
Universidad Nacional Autónoma de México, México.
Hospital General, México.
Rev Chilena Infectol. 2019 Dec;36(6):778-783. doi: 10.4067/S0716-10182019000600778.
We report six cases of female patients who, after the application by mesotherapy with platelet-rich plasma, as well as of an intradermal filler material of unknown origin, developed infection at the injection sites associated to Mycobacterium massiliense, as well as granuloma with reaction to foreign body. Although the cultures were negative, the identification of the microorganism was achieved by extraction of soft tissue DNA obtained by biopsy and sequencing the obtained product, with which the therapy was redirected against the particular species. Due to the great similarity in the culture between M. massiliense with the related species M. abscessus, to the required time for its growth, and to the different therapeutic response of each strain, molecular diagnostic techniques are a real option to consider to administer in an early way the appropriate treatment against the pathogen and prevent infection progression.
我们报告了6例女性患者,她们在接受富含血小板血浆的中胚层疗法以及一种来源不明的真皮填充材料治疗后,注射部位出现了与马赛分枝杆菌相关的感染以及异物反应性肉芽肿。尽管培养结果为阴性,但通过活检获取软组织DNA并对所得产物进行测序实现了微生物的鉴定,据此调整了针对该特定菌种的治疗方案。由于马赛分枝杆菌与相关菌种脓肿分枝杆菌在培养方面极为相似,其生长所需时间较长,且各菌株的治疗反应不同,分子诊断技术是一个切实可行的选择,可考虑尽早应用以针对病原体进行适当治疗并防止感染进展。